This study investigates how gastrointestinal toxicity affects discontinuation of medication given to patients with osteoarthritis in routine clinical practice.

Condition : Gout Interventions : Drug: Arhalofenate 600 mg; Drug: Allopurinol 300 mg; Drug: Colchicine 0.6 mg; Drug: Placebo; Drug: Arhalofenate 800 mg Sponsor : CymaBay Therapeutics, Inc. Not yet rec...

Condition : Bilateral Knee Osteoarthritis Intervention : Other: Hyaluronic acid Sponsor : University of Malaya Completed - verified February 2014

Conditions : Primary or Secondary Osteoarthritis; Post-traumatic Osteoarthritis of Hip Nos; Femur Head Necrosis; Femur Neck Fracture; Congenital Dislocations Intervention : Sponsor : Tornier Completed...

Condition : Knee Osteoarthritis Interventions : Other: Laser Therapy; Other: Electrical Stimulation Sponsors : Federal University of Rio Grande do Sul; Marco Aurélio Vaz, PhD; Fundação de Amparo à Pes...

Condition : Primary Gout Interventions : Drug: Diacerein; Drug: Colchicine; Drug: Febuxostat Sponsor : Tongji Hospital Recruiting - verified February 2014

Conditions : Necrosis of Femoral Head; Knee Osteoarthritis; Fracture of Lower Limb Intervention : Sponsor : RenJi Hospital Not yet recruiting - verified February 2014

Condition : Knee Osteoarthritis Intervention : Device: Neuromuscular Electrical Stimlation (NMES) Sponsor : Federal University of Rio Grande do Sul Completed - verified February 2014

Conditions : Osteoarthritis; Total Knee Arthroplasty Interventions : Other: continuous passive motion (CPM); Other: controlled active motion (CAM I); Other: controlled active motion (CAM II) Sponsors...

Condition : Osteoarthritis Intervention : Drug: Tranexamic Acid Sponsors : Lawson Health Research Institute; University of Western Ontario, Canada Not yet recruiting - verified February 2014